These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6549134)

  • 1. Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.
    Mattern J; Keppler B; Volm M
    Arzneimittelforschung; 1984; 34(10):1289-90. PubMed ID: 6549134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
    Keller HJ; Keppler B; Schmähl D
    Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of human non-small cell lung cancer xenografts to cyclophosphamide and cisplatin.
    Mattern J; Wayss K; Volm M
    In Vivo; 1987; 1(1):23-6. PubMed ID: 2856516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium (IV) compounds. A new class of antineoplastic agents.
    Keller HJ; Keppler B; Schmähl D
    J Cancer Res Clin Oncol; 1983; 105(1):109-10. PubMed ID: 6682104
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.
    Kurihara N; Kubota T; Hoshiya Y; Otani Y; Watanabe M; Kumai K; Kitajima M
    J Surg Oncol; 1996 Feb; 61(2):138-42. PubMed ID: 8606546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autochthonous, acetoxymethylmethylnitrosamine-induced colorectal cancer in rats: a useful tool in selecting new active antineoplastic compounds?
    Berger MR; Bischoff H; Garzon FT; Schmähl D
    Hepatogastroenterology; 1986 Oct; 33(5):227-34. PubMed ID: 3804178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
    Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
    Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds.
    Keppler BK; Diez A; Seifried V
    Arzneimittelforschung; 1985; 35(12):1832-6. PubMed ID: 4096739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
    Mattern J; Wayss K; Volm M
    J Natl Cancer Inst; 1984 Jun; 72(6):1335-9. PubMed ID: 6587154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
    Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
    Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
    Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).
    Winograd B; Boven E; Lobbezoo MW; Pinedo HM
    In Vivo; 1987; 1(1):1-13. PubMed ID: 2979758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic response of human lung tumour xenografts to cyclophosphamide.
    Mattern J; Jaeger S; Wayss K; Volm M
    Anticancer Res; 1982; 2(6):355-8. PubMed ID: 7168553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
    Geiger T; Müller M; Monia BP; Fabbro D
    Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
    Kelland LR
    Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of taxol on human tumors transplanted in athymic mice].
    Jacrot M; Riondel J; Picot F; Leroux D; Mouriquand C; Beriel H; Potier P
    C R Seances Acad Sci III; 1983; 297(13):597-600. PubMed ID: 6143600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
    Schiller JH; Bittner G
    Clin Cancer Res; 1999 Dec; 5(12):4287-94. PubMed ID: 10632372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.